PALB2 and cancer: Furthermore, BCAC and Cancer Risks Estimates Related to Susceptibility Consortium (CARRIERS), suggested BRCA1, BRCA2, ATM, PALB2, and CHEK2 genes as highly penetrant; both consortiums pinpointed that 10% of BC patients have cancer susceptibility germline mutation [3].